In August last year, Kishan et al. showed a preliminary analysis of oncological outcomes among patients diagnosed with Gleason score 9 and 10 and treated with brachy boost therapy (EBRT + BT), external beam radiation therapy alone (EBRT), or surgery (see this link). … READ MORE …
Filed under: Management, Treatment | Tagged: "high risk", boost, brachy, BT, EBRT, outcome | 8 Comments »